WallStSmart

Aehr Test Systems (AEHR)vsLam Research Corp (LRCX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lam Research Corp generates 47810% more annual revenue ($21.68B vs $45.26M). LRCX leads profitability with a 30.9% profit margin vs -25.2%. AEHR appears more attractively valued with a PEG of 0.90. LRCX earns a higher WallStSmart Score of 74/100 (B).

AEHR

Avoid

28

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.0Quality: 8.5
Piotroski: 2/9Altman Z: 3.55

LRCX

Strong Buy

74

out of 100

Grade: B

Growth: 7.3Profit: 10.0Value: 4.0Quality: 8.5
Piotroski: 6/9Altman Z: 4.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AEHR.

LRCXUndervalued (+1.7%)

Margin of Safety

+1.7%

Fair Value

$329.99

Current Price

$303.28

$26.71 discount

UndervaluedFair: $329.99Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AEHR3 strengths · Avg: 9.3/10
Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.5510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.908/10

Growing faster than its price suggests

LRCX6 strengths · Avg: 9.7/10
Market CapQuality
$418.20B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
63.4%10/10

Every $100 of equity generates 63 in profit

Profit MarginProfitability
30.9%10/10

Keeps 31 of every $100 in revenue as profit

Operating MarginProfitability
35.0%10/10

Strong operational efficiency at 35.0%

Altman Z-ScoreHealth
4.6510/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
23.8%8/10

Revenue surging 23.8% year-over-year

Areas to Watch

AEHR4 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Price/BookValuation
26.0x2/10

Trading at 26.0x book value

Return on EquityProfitability
-8.2%2/10

ROE of -8.2% — below average capital efficiency

Revenue GrowthGrowth
-43.7%2/10

Revenue declined 43.7%

LRCX3 concerns · Avg: 2.7/10
PEG RatioValuation
1.854/10

Expensive relative to growth rate

P/E RatioValuation
63.3x2/10

Premium valuation, high expectations priced in

Price/BookValuation
35.8x2/10

Trading at 35.8x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : AEHR

The strongest argument for AEHR centers on Debt/Equity, Altman Z-Score, PEG Ratio. PEG of 0.90 suggests the stock is reasonably priced for its growth.

Bull Case : LRCX

The strongest argument for LRCX centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 30.9% and operating margin at 35.0%. Revenue growth of 23.8% demonstrates continued momentum.

Bear Case : AEHR

The primary concerns for AEHR are Piotroski F-Score, Price/Book, Return on Equity.

Bear Case : LRCX

The primary concerns for LRCX are PEG Ratio, P/E Ratio, Price/Book. A P/E of 63.3x leaves little room for execution misses.

Key Dynamics to Monitor

AEHR profiles as a turnaround stock while LRCX is a growth play — different risk/reward profiles.

AEHR carries more volatility with a beta of 3.27 — expect wider price swings.

LRCX is growing revenue faster at 23.8% — sustainability is the question.

LRCX generates stronger free cash flow (810M), providing more financial flexibility.

Bottom Line

LRCX scores higher overall (74/100 vs 28/100), backed by strong 30.9% margins and 23.8% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aehr Test Systems

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

Aehr Test Systems primarily designs, designs, manufactures and sells test and burn equipment for use in the semiconductor industry in the United States, Asia and Europe. The company is headquartered in Fremont, California.

Visit Website →

Lam Research Corp

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

Lam Research Corporation is an American corporation that engages in the design, manufacture, marketing, and service of semiconductor processing equipment used in the fabrication of integrated circuits. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices (transistors, capacitors) and their wiring (interconnects). The company also builds equipment for back-end wafer-level packaging (WLP), and for related manufacturing markets such as for microelectromechanical systems (MEMS). The company is headquartered in Fremont, California, in the Silicon Valley.

Want to dig deeper into these stocks?